Diagnostic and prognostic value of immunohistological bone marrow examination: results in 212 patients with lymphoproliferative disorders
- PMID: 3103722
- DOI: 10.1007/BF00594196
Diagnostic and prognostic value of immunohistological bone marrow examination: results in 212 patients with lymphoproliferative disorders
Abstract
Cryostat sections of 246 consecutive bone marrow biopsies from 212 patients with lymphoproliferative disease were investigated using a panel of monoclonal antibodies (MOAb's) and an immunoperoxidase technique. Bone marrow involvement was demonstrated by immunohistological examination in 121/160 patients (76%) with non-Hodgkin lymphomas (NHL) and 16/23 patients (70%) with plasma cell malignancies; the definite immunological diagnosis could be performed in 77% and 88%, respectively. Reactivity with the MoAb Ki-67 correlated with clinical parameters: in all cases exhibiting more than 5% positive cells an unfavourable course was seen, independent of the histological subtype. Another MoAb of potential prognostic relevance is KiM 4 b, which reacts with follicular dendritic cells (FDC). Besides the presence of FDC in germinal center tumors (CB/CC and CC-NHL) we found FDC in a minority of cases with B-CLL (5/44) and IC lymphoma (4/18). In the latter group 3/4 patients showed a favourable clinical course (vs 2/14 without FDC). The MoAb Tü 1 could discriminate between the lymphoplasmocytoid (11/12 positive) and the lymphoplasmocytic (0/6 positive) subtype of IC lymphoma and has proven of diagnostic importance. Expression of IL-2 receptors, detected by MoAb anti-Tac (CD 25), was demonstrated on leukemic cells from patients with hairy cell leukemia (100%), B-CLL (82%), IC (61%), CC (50%) and CB/CC lymphoma (50%). A considerable number of reactive T-lymphocytes (5%-60% of tissue cells) were identified among the neoplastic B cells with a predominance of CD4+ cells in most cases with NHL, whereas the CD4+/CD8+ ratio was significantly lower in myelomas and non-infiltrated bone marrows. The potential meaning of these findings is discussed. The immunohistological bone marrow analysis represents an important additional method in the diagnostic procedures of lymphoproliferative diseases involving the bone.
Similar articles
-
[Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].Onkologie. 1986 Apr;9(2):108-13. doi: 10.1159/000215974. Onkologie. 1986. PMID: 3520418 German.
-
Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.Am J Pathol. 1987 Apr;127(1):27-37. Am J Pathol. 1987. PMID: 3105322 Free PMC article.
-
Immunopathology of non-Hodgkin lymphomas.Klin Wochenschr. 1984 Nov 2;62(21):1001-10. doi: 10.1007/BF01711721. Klin Wochenschr. 1984. PMID: 6392723
-
Bone marrow involvement by hodgkin and non-hodgkin lymphomas.Hematol Oncol Clin North Am. 2009 Aug;23(4):873-902. doi: 10.1016/j.hoc.2009.04.014. Hematol Oncol Clin North Am. 2009. PMID: 19577173 Review.
-
Cell surface markers in leukemia: biological and clinical correlations.Crit Rev Oncol Hematol. 1985;2(3):209-60. doi: 10.1016/s1040-8428(85)80003-2. Crit Rev Oncol Hematol. 1985. PMID: 3013441 Review.
Cited by
-
Bone marrow lymphocyte subsets in myelodysplastic syndromes.J Clin Pathol. 1994 Jun;47(6):505-7. doi: 10.1136/jcp.47.6.505. J Clin Pathol. 1994. PMID: 8063930 Free PMC article.
-
Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia.Front Biosci (Schol Ed). 2012 Jan 1;4(1):61-73. doi: 10.2741/s251. Front Biosci (Schol Ed). 2012. PMID: 22202043 Free PMC article. Review.
-
Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.Clin Exp Immunol. 1989 Aug;77(2):234-8. Clin Exp Immunol. 1989. PMID: 2673591 Free PMC article.
-
Osteosclerotic myeloma with polyneuropathy and hypocalcemia.Blut. 1989 Apr;58(4):207-10. doi: 10.1007/BF00320775. Blut. 1989. PMID: 2539870 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials